A service of StreetInsider.com
Ticker Symbol
Welcome

Most Popular

AAPL 493.17
C 33.66
GOOG 611.46
BAC 8.18
RIMM 15.90

Recently Added

CPIC 1.19
SHMX 0.00
NBTH 12.50
COHO 0.00
PZZI 4.71

Gaining Speed

COHO 0.00
SHMX 0.00
CPIC 1.19
NBTH 12.50
AVEW 0.00
2.39 +0.00 (0.00%) YMI

Click Here to Receive Instant E-mail and RSS Alerts


Trade YMI now with

Stock Details

Last Trade:2.39 Change:+0.00 (0.00%) Prev Close:2.39 Open: 2.40 Days Range:2.35 – 2.43 52 Week Range: 1.03 - 3.78 Volume:100 P/E: N/A
EPS:0.00





Recent Blog Posts

Blog Posts on 01/24/12 at 3:49pm
Jakafi Launch: Survey Reveals Upside To Stock
Blog Posts on 12/19/11 at 5:20am
5 Winners Of American Society Of Hematology 2011
Blog Posts on 12/15/11 at 9:26am
YM's Positive Results Have Incyte Investors Worried
Blog Posts on 12/08/11 at 9:07am
Q3 Micro-Cap Biotech Picks By The World's Largest Fund Managers
Blog Posts on 11/23/11 at 4:19pm
20 Healthcare Stocks Deeply Undervalued By Target Price
Blog Posts on 11/18/11 at 10:15am
Top Q3 Picks Of Biotech-Focused Hedge Fund DAFNA Capital
Blog Posts on 11/14/11 at 9:00am
Incyte JAK Inhibitor Awaits Certain Approval
Blog Posts on 11/04/11 at 3:23am
Oxigene Headed Back Down On Disappointing Zybrestat Results
Blog Posts on 11/02/11 at 5:18am
6 Biotech Stocks Analysts Expect To Double In 2012
Blog Posts on 11/01/11 at 10:14am
YM BioSciences' Upcoming CYT387 Catalyst May Be One To Watch
Blog Posts on 10/20/11 at 1:03pm
Oxigene Is Up 60% On Wild Speculation But It's Bound To Decline
Blog Posts on 10/14/11 at 12:37pm
Top Fund Managers' Small Cap Biotech Picks
Blog Posts on 10/11/11 at 8:02am
19 Small Cap Stocks Boosted By Institutional Buying
Blog Posts on 10/03/11 at 4:39am
8 Speculative Biotech Buys Based On Last Quarter's Biggest Movers
Blog Posts on 09/23/11 at 3:53pm
Emisphere: A Call Option On Novartis-Supported Catalyst
Blog Posts on 07/15/11 at 11:16am
Uplisting May Be Next For ImmunoCellular Therapeutics
Blog Posts on 07/05/11 at 5:51am
5 Oncology Drugs Available for Partnering (Part II)
Blog Posts on 06/02/11 at 8:32am
Drugs to Watch at ASCO 2011
Blog Posts on 05/24/11 at 8:46am
24 Stocks Under $5 Undervalued Relative to Target Price
Blog Posts on 05/16/11 at 10:17am
Top Picks by Biotech and Medical Device Focused Hedge Fund DAFNA Capital Management
Blog Posts on 05/09/11 at 5:56am
A Simplified ASCO 2011 List for Biotech Investor Research
Blog Posts on 05/02/11 at 9:14am
ASCO 2011: Opportunities for Biotech Investor Success and Failure
Blog Posts on 04/28/11 at 1:05pm
17 Stocks Under $5 Being Chased by Big Money Managers
Blog Posts on 04/21/11 at 11:28am
Incyte and YM Biosciences in Race to Market Strongest JAK Inhibitor
Blog Posts on 03/28/11 at 9:25am
YM Biosciences' Worrisome Business Model
Blog Posts on 12/28/10 at 3:50am
BioSante Attracts Institutional Investors Ahead of Key FDA Catalysts in 2011
Blog Posts on 12/20/10 at 1:51am
The Winner of ASH 2010: Seattle Genetics
Blog Posts on 06/15/10 at 1:32pm
YM BioSciences Reshuffles the Cytopia Deck
Blog Posts on 06/09/10 at 3:59am
Curtain Closes on ASCO: 2010's Few Winners
Blog Posts on 06/02/10 at 3:19am
Predictions for Biotech Data Heading to ASCO